VIR BIOTECHNOLOGY, INC. (VIR) Social Stream



VIR BIOTECHNOLOGY, INC. (VIR): $22.82

-1.32 (-5.47%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add VIR to Watchlist
Sign Up

Industry: Biotech


Ranked

of 392

in industry

Vir Biotechnology Inc (VIR) Price Targets From Analysts

Use the tables below to see what analysts covering Vir Biotechnology Inc think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-05 5 $135 $37 $75.6 $25.33 198.46%
2021-11-11 5 $135 $36 $75.4 $25.33 197.67%
2021-11-30 5 $200 $36 $88.4 $25.33 248.99%
2022-01-31 6 $300 $36 $108.4 $25.33 327.95%
2022-02-01 6 $300 $36 $96.333 $25.33 280.31%
2022-02-25 5 $300 $36.001 $106.4 $25.33 320.06%
2022-03-03 6 $300 $28 $93.333 $25.33 268.47%
2022-03-30 6 $200 $28 $76 $25.33 200.04%

The Trend in the Analyst Price Target


Over the past 46 weeks, VIR's average price target has gone down $12.4.

VIR reports an average of 124.09% for its upside potential over the past 51 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-25 2 135 65.000 88.400 48.91 80.74%
2021-09-18 7 135 29.000 69.860 54.54 28.09%
2022-02-01 6 300 36.001 108.400 35.18 208.13%
2022-02-01 6 300 36.000 96.333 35.18 173.83%
2022-03-03 6 300 28.000 96.000 24.30 295.06%

VIR Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.67 4 0 2 0 0 6

The Trend in the Broker Recommendations


VIR's average broker recommendation rating improved by 0.33 over the prior 90 days.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • VIR has a lower variance in analysts' estimates than -990.49% of all US stocks.
  • Vir Biotechnology Inc's upside potential (average analyst target price relative to current price) is greater than 1038.8% of stocks in the mid market cap category.
  • In the context of Pharmaceutical Products stocks, Vir Biotechnology Inc's average analyst price target is greater than 927.11% of them.
  • In the context of stocks in the mid market cap category, Vir Biotechnology Inc's number of analysts covering the stock is greater than 352.97% of them.

Stocks similar to Vir Biotechnology Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are VCEL, TIL, and SWTX.

What is the outlook for VIR? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4681 seconds.